TherapeuticsMD TXMD
NASDAQ TXMD
$1.74 +0.06 (+3.57%)
At close: Nov 10, 2026 · 4:00 PM EST

TherapeuticsMD (TXMD) Liabilities and Shareholders Equity (2009 - 2026)

Updated

Analysis

TherapeuticsMD (TXMD) Liabilities and Shareholders Equity (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 197.43 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 147.68 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 119.92 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 51.41 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 205.00 Bn
10 TherapeuticsMD 20.14 Mn -12.07 Mn - 37.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.53 Mn
Mar 31, 2026 37.58 Mn
Dec 31, 2025 37.66 Mn
Sep 30, 2025 38.67 Mn
Jun 30, 2025 38.50 Mn
Mar 31, 2025 38.24 Mn
Dec 31, 2024 38.82 Mn
Sep 30, 2024 39.55 Mn
Jun 30, 2024 40.13 Mn
Mar 31, 2024 42.09 Mn
Dec 31, 2023 43.31 Mn
Sep 30, 2023 50.49 Mn
Jun 30, 2023 53.69 Mn
Mar 31, 2023 59.60 Mn
Dec 31, 2022 90.46 Mn
Sep 30, 2022 133.91 Mn
Jun 30, 2022 146.20 Mn
Mar 31, 2022 133.38 Mn
Dec 31, 2021 169.47 Mn
Sep 30, 2021 209.63 Mn
API Access

TherapeuticsMD Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=TXMD&period=max&api_key=YOUR_API_KEY